ThereAbouts Agreed : the lack of interest to such an extent that...

ThereAbouts
Agreed : the lack of interest to such an extent that caused the delay of listing, issue of Supp Prospectus, and downgrading of min acceptance all says this is not likely to be a quick stag opportunity ! But I can advise that the science here is very solid. The molecular biology based technique they utilize to enable detection is exquisite and has huge advantages over traditional techniques - albeit more expensive. Their diagnostics have a big future. But biotechs seem to attract an expectation that there will be some blockbuster breakthrough to allow shareholders to bank buckets quickly. GSS does not have the excitement factor to attract investors like say POH, CYP or VLR to name some recent fliers, and I think that is the reason for the lack of interest in the IPO. But the science is very solid. I know the science very well from previous commercial involvement with such products in Aust and USA. I hasten to add that I am not connected in any way to GSS, but have watched them for months and now that its crunch time I think I just have to participate. But expect the upside to be quite slow and steady. All IMO of course and DYOR